NKTR Competitors & Alternatives
Compare Nektar Therapeutics with similar stocks in the same industry
Biotechnology
NKTR
Main Stock$69.76
Tradestie Score
56
Market Cap
$1.12B
Revenue Growth
-0.1%
Analyst Upside
+107.0%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$23.99
|
$2.44B | - | 37 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$79.31
|
$2.42B | - | 37 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$173.79
|
$2.41B | - | 35 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.59
|
$2.40B | - | 45 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$23.89
|
$2.37B | 106.3 | 53 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.91
|
$2.34B | - | 40 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$70.06
|
$2.33B | - | 53 | Compare |
More NKTR Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry